Eyal Flom

Director/Board Member presso INNOCAN PHARMA CORPORATION

Patrimonio netto: 534 437 $ in data 31/03/2024

59 anni

16 relazioni

Health Technology

Consumer Services

Distribution Services

Profilo

Eyal Flom is currently the Director at Revium Recovery, Inc. He is also the Secretary & Director at InnoCan Pharma Corp.
and the Director at NurExone Biologic Ltd.
In the past, he served as the Legal Counsel at the Israeli Pharmaceutical Association.
Mr. Flom's former job includes being the Director at NurExone Biologic, Inc. Mr. Flom holds an MBA from the University of Derby and a graduate degree from Tel-Aviv University.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
INNOCAN PHARMA CORPORATION 0.89%	25/03/2024	2 375 277 ( 0.89% )	534 437 $	31/03/2024

Posizioni attive di Eyal Flom

Società	Posizione	Inizio
INNOCAN PHARMA CORPORATION	Director/Board Member	25/09/2019
REVIUM RECOVERY INC.	Director/Board Member	-
Israeli Pharmaceutical Association	General Counsel	01/04/1995
NurExone Biologic Ltd. NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The private company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022.	Director/Board Member	-

Tutte le posizioni attive di Eyal Flom

Precedenti posizioni note di Eyal Flom

Società	Posizione	Fine
NUREXONE BIOLOGIC INC.	Director/Board Member	08/05/2023

Vedi nel dettaglio l'esperienza di Eyal Flom

Formazione di Eyal Flom

University of Derby	Masters Business Admin
Tel-Aviv University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Eyal Flom

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
REVIUM RECOVERY INC.	Distribution Services
INNOCAN PHARMA CORPORATION	Health Technology
NUREXONE BIOLOGIC INC.	Health Technology

Aziende private	2
Israeli Pharmaceutical Association
NurExone Biologic Ltd. NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The private company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022.	Health Technology